3.18
Penn in the News
A round-up of Penn mentions in local, national, and international media.
Filter Stories
Displaying 21 - 30 of 7143
Penn In the News
Have you wished your mother a happy International Women’s Day yet?
Kristen Ghodsee of the School of Arts and Sciences shared the socialist origins of International Women’s Day and how it might serve as a contemporary, feminist alternative to Mother’s Day.
Penn In the News
Amid marketing and social-media onslaughts, Gen Z women have to find ourselves
Sophomore Claire Sliney of Los Angeles wrote an op-ed about efforts by women of her generation to “develop our own authentic identities in this world inundated with nonstop content and manipulative marketing.”
Penn In the News
The push is on at college career centers: They work with students earlier and alumni decades later
Career Services’ Barbara Hewitt spoke about Penn’s lifelong support for alumni seeking career guidance.
Penn In the News
Why Penn, Drexel are recruiting retailers, not just students
Ed Datz, Penn’s executive director of real estate, and Assistant Vice President Tony Sorrentino spoke about the role of retail on and near college campuses.
Penn In the News
How UPenn cut counseling wait times in half without hiring more counselors
Meeta Kumar and other Counseling and Psychological Services staffers spoke about their efforts to increase access to mental health care on Penn’s campus. To cut wait times in half, administrators studied data and student complaints, empowered frontline employees, and helped counselors balance their caseloads.
Penn In the News
U of Pennsylvania to rename design school for Stuart Weitzman
Alumnus Stuart Weitzman and his wife Jane were highlighted for their contributions to the School of Design. The gift, commemorated by the school’s new name, will go toward financial aid and academic programming as well as a redesign of the School’s central plaza.
Penn In the News
Esketamine is the newest drug approved for depression. Here are 7 things to know about it
Michael Thase of the Perelman School of Medicine discussed esketamine, a newly FDA-approved nasal spray developed to combat treatment-resistant depression. Derived from ketamine, the drug is meant to be administered under a doctor’s supervision due to the possibility of temporary anesthetic or hallucinogenic effects.
Penn In the News
Dog-walking can be hazardous for seniors, study suggests
New research from the Perelman School of Medicine warned seniors about “a significant and rising injury rate” from walking their dogs. Jaimo Ahn, who co-authored the study, said their findings aren’t meant to discourage dog-walking, but rather to increase awareness of the risks.
Penn In the News
You have questions about Robert Mueller’s investigation. Here are the answers
Kathleen Hall Jamieson of the Annenberg School for Communication was cited for her research, which concluded that it’s very likely that Russia did indeed affect the outcome of the 2016 election.
Penn In the News
An H.I.V. cure: Answers to 4 key questions
HIV research coming out of Penn suggests that stem cell infusions may be an effective treatment for the disease.